Trial Profile
MK0476 phase III open label exploratory comparative clinical study -acute exacerbations of asthma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary) ; Aminophylline
- Indications Acute asthma
- Focus Therapeutic Use
- Sponsors Merck & Co; Organon
- 21 Jul 2009 Actual patient numbers amended from 90 to 91 as reported by ClinicalTrials.gov.
- 11 Aug 2008 Actual study completion date (1 Aug 2007) added as reported by ClinicalTrials.gov.
- 11 Aug 2008 Actual number of patients is now 90 as reported by ClinicalTrials.gov.